Lapatinib base
CAS:231277-92-2
Specification: Assay 99%
Molecular Formula:C29H26ClFN4O4S
Molecular Weight:581.0575432g/mol
Description:lapatinib could be used as a first-line therapy regimen combined with anti-hormonal therapy for patients with hormone-sensitive, metastatic (or advanced) breast cancer in Europe and the United States.
For more information OR other specifications of the products, please contact us.
Send Enquiry Online
For more information OR other products. Please contact us by Email, Tel or Send online enquiry. We will reply you as soon as possible.
1. E-mail: sales(at)aisere.com
2. Tel: +86 592 580 6672
If you are interested in our product, want to know more about product information, please contact us, we are professional products manufacturers, our price concessions, professional level produce things cheap beauty products, welcomed the consultation.
